Cargando…
Vaccine allocation in a declining epidemic
Sizeable quantities of 2009 pandemic influenza A/H1N1 (H1N1pdm) vaccine in the USA became available at the end of 2009 when the autumn wave of the epidemic was declining. At that point, risk factors for H1N1-related mortality for some of the high-risk groups, particularly adults with underlying heal...
Autores principales: | Goldstein, E., Wallinga, J., Lipsitch, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479926/ https://www.ncbi.nlm.nih.gov/pubmed/22772378 http://dx.doi.org/10.1098/rsif.2012.0404 |
Ejemplares similares
-
Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritization
por: Miura, Fuminari, et al.
Publicado: (2021) -
Optimizing Vaccine Allocation at Different Points in Time during an Epidemic
por: Matrajt, Laura, et al.
Publicado: (2010) -
A Measles Epidemic Threshold in a Highly Vaccinated Population
por: Wallinga, Jacco, et al.
Publicado: (2005) -
Variation in loss of immunity shapes influenza epidemics and the impact of vaccination
por: Woolthuis, Rutger G., et al.
Publicado: (2017) -
On the role of different age groups during pertussis epidemics in California, 2010 and 2014
por: Mahmud, A. S., et al.
Publicado: (2019)